1/2 Howard/Hopkins Intercenter Collaboration in HPV-Associated Cancer Studies
1/2 Howard/Hopkins Intercenter Collaboration in HPV-Associated Cancer Studies
批准号:
8850130
负责人:
XIAOWU PANG
金额:
$18.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-20 至 2018-08-31
关键词:
AccountingAddressAfrican AmericanApplications GrantsAreaAttitudeAwarenessBaltimoreCancer CenterCancer Research ProjectCaucasiansCaucasoid RaceCollaborationsCommitCommunitiesComprehensive Cancer CenterDataDentalDental FacilitiesDental FacultyDental StudentsDentistryDentistsDevelopmentDiagnosisDistrict of ColumbiaEducationEnsureEpidemiologic StudiesEtiologyFaceFacultyFundingFunding OpportunitiesGoalsGrantHead and Neck CancerHealthHealth educationHispanicsHistorically Black Colleges and UniversitiesHome environmentHuman Papilloma Virus VaccineHuman PapillomavirusHuman papillomavirus 16IncidenceInstitutionKnowledgeLeadLearningMalignant NeoplasmsMalignant Vaginal NeoplasmMalignant neoplasm of anusMalignant neoplasm of cervix uteriMarylandMedicalMedical ResearchMedical StudentsMedicineMentorsMentorshipMinorityMinority-Serving InstitutionMotivationNCI-Designated Cancer CenterNational Cancer InstituteOral cavityOropharyngealParticipantPatientsPilot ProjectsPopulationPreparationPreventionProcessPublicationsResearchResearch PersonnelResearch Project GrantsResearch TrainingResourcesScientistServicesStudentsSystemTrainingTraining and EducationTranslational ResearchUnderrepresented MinorityUnderserved PopulationUnited StatesUnited States National Institutes of HealthUniversitiesWashingtonWomananticancer researchbasecancer diagnosiscancer educationcancer health disparitycareercareer developmentcohortcollegehealth disparityimprovedmalignant mouth neoplasmmalignant oropharynx neoplasmmetropolitanmouse modelmultidisciplinaryprogramspublic health relevancereproductiveskillssocioeconomicsundergraduate studentuniversity studentvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal aims to improve the translational and community-based HPV-associated cancer research, education, and training at Howard University through collaborative projects and an effective long-term partnership with Johns Hopkins Medical Institutions Sidney Kimmel Comprehensive Cancer Center. Human papillomavirus (HPV) accounts for 5.2% of cancer cases worldwide. Several strains of HPV cause a variety of devastating reproductive and oropharyngeal cancers. In the United States, about 26,700 cases of HPV-associated cancers are diagnosed annually. African American women suffer from a significantly higher incidence rate of HPV-associated cervical, vaginal, and anal cancers compared to their Caucasian counterparts. Additionally, HPV-16 has been identified in approximately 20-30% of head and neck cancers and roughly 56% of oropharynx and oral cavity cancers. Howard University Medical Institutions have a historically Black student body, and its medical and dental facilities participate in direct service to minority populations. However, Howard University faces significant challenges in cancer research and health disparities efforts. Johns Hopkins is committed to providing mentorship and educational resources in cancer research to improve Howard's capacities. Howard is a leading minority-serving institution, while Johns Hopkins is a well-established NCI-designated Cancer Center. An educational effort that brings together Howard doctors and dentists who focus on minorities and Johns Hopkins researchers who study HPV-related cancers will help to address socioeconomic disparities and barriers to cancer health, health education, and health-related professions. Through a set of collaborative pilot projects that include HPV vaccine development in mice models, epidemiology research in a Washington D.C. community cohort, and an extensive mentoring network between the two universities, this collaboration will significantly enhance career development, education, and competitiveness in seeking funding opportunities for Howard students and educators. Specific aims will be: 1) to support collaborative cancer research projects between the Howard University Medical Institutions and the Sidney Kimmel Cancer Center at Johns Hopkins; 2) to provide collaborative training and mentoring programs for promoting Howard medical and dental students and faculty in cancer research, 3) to establish education programs that advance the knowledge of cancer research as it applies to etiology, prevention, diagnosis, and treatment of HPV-associated cancer in the context of minority-serving institutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing Vertebrate-Specific Replication-Defective Dengue Virus as Novel Single-CycleDengue Vaccine Candidate
-
批准号:10553634
-
项目类别:
-
资助金额:$29.85万
-
财政年份:2022
-
负责人:XIAOWU PANG
-
依托单位:
Developing Vertebrate-Specific Replication-Defective Dengue Virus as Novel Single-CycleDengue Vaccine Candidate
-
批准号:10384489
-
项目类别:
-
资助金额:$29.85万
-
财政年份:2022
-
负责人:XIAOWU PANG
-
依托单位:
Development of Zika viral pseudoinfectious virus as Zika vaccine candidate
-
批准号:10304384
-
项目类别:
-
资助金额:$5.2万
-
财政年份:2021
-
负责人:XIAOWU PANG
-
依托单位:
Development of Zika viral pseudoinfectious virus as Zika vaccine candidate
-
批准号:9536650
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2017
-
负责人:XIAOWU PANG
-
依托单位:
Development of a ZIKA viral pseudoinfectious virus as ZIKA vaccine candidate (STTR Phase II)
-
批准号:10612753
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2017
-
负责人:XIAOWU PANG
-
依托单位:
Development of a ZIKA viral pseudoinfectious virus as ZIKA vaccine candidate (STTR Phase II)
-
批准号:10397160
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2017
-
负责人:XIAOWU PANG
-
依托单位:
Development of a ZIKA viral pseudoinfectious virus as ZIKA vaccine candidate (STTR Phase II)
-
批准号:10259140
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2017
-
负责人:XIAOWU PANG
-
依托单位:
1/2 Howard/Hopkins Intercenter Collaboration in HPV-Associated Cancer Studies
-
批准号:9132724
-
项目类别:
-
资助金额:$22.03万
-
财政年份:2014
-
负责人:XIAOWU PANG
-
依托单位:
Administration Core
-
批准号:8850131
-
项目类别:
-
资助金额:$18.06万
-
财政年份:2014
-
负责人:XIAOWU PANG
-
依托单位:
Development of Pseudoinfectious VLP as Novel JEV Vaccine
-
批准号:7280433
-
项目类别:
-
资助金额:$28.45万
-
财政年份:2006
-
负责人:XIAOWU PANG
-
依托单位:
Development of Pseudoinfectious VLP as Novel JEV Vaccine
-
批准号:7161686
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2006
-
负责人:XIAOWU PANG
-
依托单位:
Project 1, Combination Immunotherapy for HPV-Associated Cancer
-
批准号:9341169
-
项目类别:
-
资助金额:$5.61万
-
财政年份:--
-
负责人:XIAOWU PANG
-
依托单位:
Project 1, Combination Immunotherapy for HPV-Associated Cancer
-
批准号:8934340
-
项目类别:
-
资助金额:$6.55万
-
财政年份:--
-
负责人:XIAOWU PANG
-
依托单位:
海外基金